Study: NCT00133471

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza A/H9N2 vaccine
Description: A single lot of monovalent inactivated SA influenza A/H9N2 vaccine. All injections will be administered in a 0.5-mL volume into the deltoid muscle. Dosage levels are: 3.75-, 7.5-, 15-, and 30-mcg of HA of the vaccine strain with and without MF59 adjuvant.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza A/H9N2 vaccine
Description: A single lot of monovalent inactivated SA influenza A/H9N2 vaccine. All injections will be administered in a 0.5-mL volume into the deltoid muscle. Dosage levels are: 3.75-, 7.5-, 15-, and 30-mcg of HA of the vaccine strain with and without MF59 adjuvant.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza A/H9N2 vaccine
Description: A single lot of monovalent inactivated SA influenza A/H9N2 vaccine. All injections will be administered in a 0.5-mL volume into the deltoid muscle. Dosage levels are: 3.75-, 7.5-, 15-, and 30-mcg of HA of the vaccine strain with and without MF59 adjuvant.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza A/H9N2 vaccine
Description: A single lot of monovalent inactivated SA influenza A/H9N2 vaccine. All injections will be administered in a 0.5-mL volume into the deltoid muscle. Dosage levels are: 3.75-, 7.5-, 15-, and 30-mcg of HA of the vaccine strain with and without MF59 adjuvant.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza A/H9N2 vaccine
Description: A single lot of monovalent inactivated SA influenza A/H9N2 vaccine. All injections will be administered in a 0.5-mL volume into the deltoid muscle. Dosage levels are: 3.75-, 7.5-, 15-, and 30-mcg of HA of the vaccine strain with and without MF59 adjuvant.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza A/H9N2 vaccine
Description: A single lot of monovalent inactivated SA influenza A/H9N2 vaccine. All injections will be administered in a 0.5-mL volume into the deltoid muscle. Dosage levels are: 3.75-, 7.5-, 15-, and 30-mcg of HA of the vaccine strain with and without MF59 adjuvant.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza A/H9N2 vaccine
Description: A single lot of monovalent inactivated SA influenza A/H9N2 vaccine. All injections will be administered in a 0.5-mL volume into the deltoid muscle. Dosage levels are: 3.75-, 7.5-, 15-, and 30-mcg of HA of the vaccine strain with and without MF59 adjuvant.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza A/H9N2 vaccine
Description: A single lot of monovalent inactivated SA influenza A/H9N2 vaccine. All injections will be administered in a 0.5-mL volume into the deltoid muscle. Dosage levels are: 3.75-, 7.5-, 15-, and 30-mcg of HA of the vaccine strain with and without MF59 adjuvant.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MF59 adjuvant
Description: MF59 adjuvant is an oil-in-water emulsion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MF59 adjuvant
Description: MF59 adjuvant is an oil-in-water emulsion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MF59 adjuvant
Description: MF59 adjuvant is an oil-in-water emulsion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MF59 adjuvant
Description: MF59 adjuvant is an oil-in-water emulsion.